102 related articles for article (PubMed ID: 26986772)
1. Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic Therapy.
Beaudoin T; Waters V
Pediatr Infect Dis J; 2016 Jun; 35(6):695-7. PubMed ID: 26986772
[No Abstract] [Full Text] [Related]
2. Biofilms: prevention and treatment.
Rowson C; Townsend R
Br J Hosp Med (Lond); 2016 Dec; 77(12):699-703. PubMed ID: 27937018
[TBL] [Abstract][Full Text] [Related]
3. [Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].
Lebeaux D; Ghigo JM
Med Sci (Paris); 2012; 28(8-9):727-39. PubMed ID: 22920875
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of biofilm infections in children.
Munro APS; Highmore CJ; Webb JS; Faust SN
Curr Opin Infect Dis; 2019 Oct; 32(5):505-509. PubMed ID: 31335442
[TBL] [Abstract][Full Text] [Related]
5. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of hemodialysis catheter infections.
Ramanathan V; Darouiche RO
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1447-55. PubMed ID: 23253322
[TBL] [Abstract][Full Text] [Related]
7. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
Smith AW
Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
[TBL] [Abstract][Full Text] [Related]
8. [Mucoviscidosis. Antibiotic management].
Le Bourgeois M; Gérardin M; Munck A; Navarro J
Presse Med; 1997 May 3-10; 26(15):727-32. PubMed ID: 9183376
[No Abstract] [Full Text] [Related]
9. Anti-biofilm agents in control of device-related infections.
Ahmed S; Darouiche RO
Adv Exp Med Biol; 2015; 831():137-46. PubMed ID: 25384667
[No Abstract] [Full Text] [Related]
10. New approaches to the treatment of biofilm-related infections.
Wilkins M; Hall-Stoodley L; Allan RN; Faust SN
J Infect; 2014 Nov; 69 Suppl 1():S47-52. PubMed ID: 25240819
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.
Ciofu O; Mandsberg LF; Wang H; Høiby N
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection.
Lopes SP; Ceri H; Azevedo NF; Pereira MO
Int J Antimicrob Agents; 2012 Sep; 40(3):260-3. PubMed ID: 22770521
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-related renal failure and cystic fibrosis.
Kennedy SE; Henry RL; Rosenberg AR
J Paediatr Child Health; 2005 Jul; 41(7):382-3. PubMed ID: 16014148
[TBL] [Abstract][Full Text] [Related]
15. Microbial biofilm formation: a need to act.
Römling U; Kjelleberg S; Normark S; Nyman L; Uhlin BE; Åkerlund B
J Intern Med; 2014 Aug; 276(2):98-110. PubMed ID: 24796496
[No Abstract] [Full Text] [Related]
16. Fever associated with intravenous antibiotics in adults with cystic fibrosis.
Mallon P; Murphy P; Elborn S
Lancet; 1997 Dec; 350(9092):1676-7. PubMed ID: 9400516
[No Abstract] [Full Text] [Related]
17. [Antibiotic treatment of cystic fibrosis].
de Montalembert M; Berche P; Lenoir G
Ann Pediatr (Paris); 1991 Oct; 38(8):523-8. PubMed ID: 1746849
[TBL] [Abstract][Full Text] [Related]
18. Inhaled aminoglycosides in cystic fibrosis.
Jew LL; Hart LL
DICP; 1990; 24(7-8):711-2. PubMed ID: 2197811
[No Abstract] [Full Text] [Related]
19. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.
Yang S; Hay ID; Cameron DR; Speir M; Cui B; Su F; Peleg AY; Lithgow T; Deighton MA; Qu Y
Sci Rep; 2015 Dec; 5():18578. PubMed ID: 26687035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
